Spring into Health: Understanding Your Body's Signals with CRP & SAA

CRP & SAA

Background: Spring is a season of renewal, with changing weather patterns and increased outdoor activities, it also brings an increase in bacterial and influenza activity. Many infections start with subtle symptoms that can be easy to dismiss as "just a spring cold." But early detection is key to effective treatment and preventing minor issues from becoming major health concerns.

Introduction: Within this context, we introduce our CRP/SAA combo test. C-Reactive Protein (CRP) and Serum Amyloid A (SAA) are key inflammatory biomarkers widely used in clinical settings. While CRP has long served as the standard indicator for systemic inflammation, SAA offers complementary clinical value by rising more rapidly in response to viral infections and inflammatory stress.

What is CRP?

C-Reactive Protein (CRP) is your body's "early warning system" for inflammation. This sensitive marker rises within 6-8 hours of infection or injury, helping doctors identify issues before they escalate.

What is SAA?

Serum Amyloid A (SAA) offers enhanced sensitivity for viral infections. It is an acute-phase protein primarily synthesized by the liver in response to inflammatory stimuli. It detects inflammation even earlier than CRP, making it ideal for catching seasonal illnesses in their earliest stages.

Combined Application

When combined, CRP and SAA testing provide:

Early Detection: Identify infections before symptoms become severe
Accurate Diagnosis: Distinguish between bacterial and viral infections
Personalized Treatment: Guide appropriate medication choices
Efficient Monitoring: Track response to treatment in real-time

Clinical Value

The combined assessment of SAA and CRP provides a rapid and reliable approach for differentiating bacterial and viral infections, improving patient management in clinical settings.
The combined monitoring of SAA and CRP provides a dynamic tool for optimizing antimicrobial therapy. By distinguishing bacterial from viral infections and enabling early assessment of treatment response, this approach reduces unnecessary drug exposure, and improves patient outcomes.
The complementary kinetics of SAA and CRP provide a powerful tool for the early infection diagnosis in neonatal or pregnant populations. Their combined use enhances clinical decision-making, reduces unnecessary antibiotic exposure.

Getein’s Solutions

Getein provides SAA, CRP, SAA/CRP combo test on our Immunofluorescence and Chemiluminescence platforms. They are easy to operate, with high sensitivity and excellent specificity. The time to first result is as fast as 5 minutes.

*SAA/CRP for Immunofluorescence platforms only

Key Features

Support fingertip blood, whole blood, serum, and plasma sampling, with high patirnt acceptance, especially among children and the elderly.
Immunofluorescence platform is based on lateral flow immunoassay technology with a sandwich design, guaranteeing quick and reliable results in 5 minutes.
Flexible choices of SAA, CRP, and SAA＆CRP assays to meet clinical needs across diverse diagnostic scenarios.

Applicable Analyzer

These relevant test kits are supported on our devices:

Getein 1100, Getein 1150, Getein 1160, Getein 1180, Getein 1200, and Getein 1600

Immunofluorescence